CCA
IQMD

Castle Creek Arbitrage’s Intelligent Medicine Acquisition Corp. Class A Common Stock IQMD Stock Holding History

Castle Creek Arbitrage’s Portfolio IQMD Stock Details IQMD Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2023
Q1 		– Sell
-400,000
Closed -$4.11M – 523
2022
Q4 		$4.11M Buy
+400,000
New +$4.06M 0.36% 77

Other funds holding IQMD

Goldman Sachs
Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return
Walleye Capital
Walleye Capital New York $24B AUM 37.67% 1-Year Est. Return
CF
Cantor Fitzgerald New York $6.78B AUM 29.01% 1-Year Est. Return
Walleye Trading
Walleye Trading New York $60B AUM 42.19% 1-Year Est. Return
WAM
Wolverine Asset Management Chicago, Illinois $10.4B AUM 4.78% 1-Year Est. Return
CS
Clear Street New York $24.6B AUM 56.26% 1-Year Est. Return
TRCT
Tower Research Capital (TRC) New York $3.85B AUM 32.11% 1-Year Est. Return
AF
Allworth Financial Folsom, California $24.7B AUM 15.55% 1-Year Est. Return

Castle Creek Arbitrage's IQMD Position: Q1 2023 in Review

Castle Creek Arbitrage sold out of Intelligent Medicine Acquisition Corp. Class A Common Stock (IQMD) in Q1 2023, closing a stake of 400,000 shares — an estimated $4.11M sold.

Castle Creek Arbitrage first reported a position in IQMD in Q4 2022 and held it in 1 quarter. The position peaked at $4.11M in Q4 2022. 8 funds tracked by Wall St. Rank hold IQMD as of Q1 2023.

  • Castle Creek Arbitrage reported no remaining Intelligent Medicine Acquisition Corp. Class A Common Stock position as of Q1 2023 after selling out during the quarter.
  • Castle Creek Arbitrage sold 400,000 Intelligent Medicine Acquisition Corp. Class A Common Stock shares in Q1 2023, an estimated $4.11M.
  • Castle Creek Arbitrage first reported a position in Intelligent Medicine Acquisition Corp. Class A Common Stock in Q4 2022 and held it in 1 quarter.
  • Castle Creek Arbitrage's Intelligent Medicine Acquisition Corp. Class A Common Stock position peaked at $4.11M in Q4 2022.
  • 8 funds tracked by Wall St. Rank held Intelligent Medicine Acquisition Corp. Class A Common Stock as of Q1 2023.

Based on Castle Creek Arbitrage's 13F filing for Q1 2023, filed 15 May 2023.